Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia

British Journal of Pharmacology

Volumn 166, Issue 7, 2012, Pages 2109-2116

  Walsh, S K ^a   English, F A ^a   Crocker, I P ^b   Johns, E J ^a   Kenny, L C ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

endothelial dysfunction; PARP; peroxynitrite; pre eclampsia; reduced uterine perfusion pressure

Indexed keywords

3 NITROTYROSINE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; FEMALE; HYPERTENSION; IMMUNOREACTIVITY; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD VESSEL; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TREATMENT RESPONSE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HYPERTENSION; MESENTERIC ARTERIES; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; PRE-ECLAMPSIA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84863698698     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01906.x     Document Type: Article

References (40)

1. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, et al,. (2000). Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37: 1191-1195.
2. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164: S1-S324.
3. Anderson CM, Lopez F, Zhang HY, Pavlish K, Benoit JN, (2005). Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant sprague-dawley rat. Biol Reprod 72: 762-766.
4. Barron LA, Giardina JB, Granger JP, Khalil RA, (2001). High-salt diet enhances vascular reactivity in pregnant rats with normal and reduced uterine perfusion pressure. Hypertension 38: 730-735.
5. Beckman JS, Koppenol WH, (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: 1424-1437.
6. Cooke CL, Davidge ST, (2003). Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice. Cardiovasc Res 60: 635-642.
7. Crews JK, Herrington JN, Granger JP, Khalil RA, (2000). Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 35: 367-372.
8. Crocker IP, Kenny LC, Thornton WA, Szabo C, Baker PN, (2005). Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia. Br J Pharmacol 144: 772-780.
9. Dordevic NZ, Babic GM, Markovic SD, Ognjanovic BI, Stajn AS, Zikic RV, et al,. (2008). Oxidative stress and changes in antioxidative defense system in erythrocytes of preeclampsia in women. Reprod Toxicol 25: 213-218.
10. Eder DJ, McDonald MT, (1987). A role for brain angiotensin II in experimental pregnancy-induced hypertension in laboratory rats. Clin Exp Hypertens Preg B6: 431-451.
11. Gilbert J, Dukes M, LaMarca B, Cockrell K, Babcock S, Granger JP, (2007). Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens 20: 686-691.
12. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP, (2008). Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294: 541-550.
13. Hayman R, Brockelsby J, Kenny L, Baker P, (1999). Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Investig 6: 3-10.
14. Hayman R, Warren A, Brockelsby J, Johnson I, Baker P, (2000). Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. BJOG 107: 108-115.
15. Kaur G, Mishra S, Sehgal A, Prasad R, (2008). Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem 313: 37-44.
16. Khalil RA, Granger JP, (2002). Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283: 29-45.
17. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
18. Lewis G, (2001). Why mothers die 1997-1999. Confidential enquiry into maternal deaths. Royal College of Obstetricians and Gynaecologists: London.
19. Mazzanti L, Raffaelli F, Vignini A, Nanetti L, Vitali P, Boscarato V, et al,. (2012). Nitric oxide and peroxynitrite platelet levels in gestational hypertension and preeclampsia. Platelets 23: 26-35.
20. McCarthy FP, Drewlo S, Kingdom J, Johns EJ, Walsh SK, Kenny LC, (2011). Peroxisome proliferator activated receptor gamma as a potential therapeutic target in the treatment of preeclampsia. Hypertension 58: 280-286.
21. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
22. Nienartowicz A, Link S, Moll W, (1989). Adaptation of the uterine arcade in rats during pregnancy. J Develop Physiol 21: 101-108.
23. Oliver FJ, Menissier-de MJ, Nacci C, Decker P, Andriantsitohaina R, Muller S, et al,. (1999). Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18: 4446-4454.
24. Pacher P, Szabo C, (2008). Role of peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 173: 2-13.
25. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E, Szabo C, (2002a). The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51: 514-521.
26. Pacher P, Mabley JG, Soriano FG, Liaudet L, Szabo C, (2002b). Activation of poly(ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int J Mol Med 6: 659-664.
27. Pascoal IF, Lindheimer MD, Nalbantian-Brandt C, Umans JG, (1998). Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest 101: 464-470.
28. Radovits T, Seres L, Gero D, Berger I, Szabo C, Karck M, et al,. (2007). Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction. Exp Gerontol 42: 676-685.
29. Roggensack AM, Zhang Y, Davidge ST, (1999). Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 33: 83-89.
30. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG, (1986). Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest 77: 1312-1320.
31. Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, et al,. (2008). Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens 21: 1152-1156.
32. Soriano FG, Pacher P, Mabley J, Liaudet L, Szabo C, (2001). Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res 89: 684-691.
33. Svedas E, Nisell H, VanWijk MJ, Nikas Y, Kublickiene KR, (2002). Endothelial dysfunction in uterine circulation in preeclampsia: can estrogens improve it? Am J Obstet Gynecol 187: 1608-1616.
34. Szabo C, (2009). Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol 156: 713-727.
35. Turgut NH, Temiz TK, Bagcivan I, Turgut B, Gulturk S, Karadas B, (2008). The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model. Eur J Pharmacol 589: 180-187.
36. VanWijk MJ, Svedas E, Boer K, Nieuwland R, VanBavel E, Kublickiene KR, (2002). Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 187: 1686-1693.
37. Virag L, Szabo C, (2002). The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54: 375-429.
38. Walsh SK, English FA, Edwards EJ, Kenny LC, (2009). Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization. Hypertension 54: 345-351.
39. Wang CJ, Zhou ZG, Holmqvist A, Zhang H, Li Y, Adell G, et al,. (2009). Survivin expression quantified by Image Pro-Plus compared with visual assessment. Appl Immunohistochem Mol Morphol 17: 530-535.
40. Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JM, Netto CA, et al,. (2005). A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Brain Res Protoc 16: 58-64.